Hand grip strength correlates strongly with weekly working hours - the importance of upper limb function in multiple sclerosis
NCT ID NCT07889271
First seen Oct 22, 2026 · Last updated Oct 23, 2026 · Updated 1 time
Summary
Multiple sclerosis (MS) as leading cause of non-traumatic neurological disability in young adults has additionally to the individual's burden of disease a significant influence on their ability to work. Objective of this study is to test parameters for their correlation with weekly working hours. We will retrospectively analyse data of people with MS (pwMS) and correlate weekly working hours with demographics, Expanded Disability Status Scale (EDSS), Nine Hole Peg Test (9HPT), walking speed measured by Timed 25-Foot Walk test (T25FW), Symbol Digit Modalities Test (SDMT) and Hand Grip Strength (HGS).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
300 people
The number who actually took part.
- Started
-
Feb 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
MS patients which include the 9HPT, T25FW, HGS and SDMT at least once during the study period as part of their routine examinations
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: This cross-sectional study analyse data from MS patients using the McDonald criteria of 2024 at the MS outpatient clinic in Salzburg, Austria between February 2024 until June 2026. Measurements included the 9HPT, T25FW, HGS and SDMT at least once during the study period as part of their routine examinations Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SalzburgerLandeskliniken
Salzburg, State of Salzburg, 5020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily versus intermittent incremental vestibulo-ocular reflex adaptation as a novel treatment for dizziness in people with multiple sclerosis
- Examining the efficacy of a Home-Based exercise training intervention for wheelchair users with multiple sclerosis
- Intravoxel incoherent motion (IVIM) magnetic resonance imaging in multiple sclerosis
- Assessment of serum neurofilament-light chain (NfL) and glial fibrillary acidic protein (GFAP) levels, atrophy of the macular ganglion cell complex (GCC) by optical coherence tomography (OCT) and whole brain atrophy by MRI to predict evolution of neurological disability in multiple sclerosis patients
- Serum neurofilament-light chain and glial fibrillary acidic proten (GFAP) levels in patients from the OFSEP cohort at different landmarks of multiple sclerosis
- Can donated umbilical cord stem cells calm multiple sclerosis?